Li Yong, Tan Bi-bo, Zhao Qun, Fan Li-Qiao, Liu Yü, Hao Ying-Jie, Zhao Xüe-Feng
Department of General Surgery, The Fourth Affiliated Hospital, Hebei Medical University, Shijiazhuang, China.
Hepatogastroenterology. 2013 Jan-Feb;60(121):213-6. doi: 10.5754/hge12535.
BACKGROUND/AIMS: To evaluate the relationship between chemosensitivities in vitro and expressions of multidrug resistance (MDR) associated factors in differentiated gastric carcinomas.
Gastric carcinomas tissues of varying degree of differentiation (65 cases) were collected and chemosensitivities to 5-FU, HCPT, PTX, L-OHP, CDDP and eADM were detected by sulphorhodamine B (SRB) assay, and expressions of P-gp, GST-π, Topo IIα, p53, Bcl-2, Bax and Survivin were tested by immunohistochemical staining.
Inhibition rates of 5-FU, L-OHP and CDDP for well differentiated tumors were lower than those of poorly differentiated tumors (p<0.05). Expressions of P-gp, Bcl-2 and Survivin were higher in well differentiated than in poorly differentiated carcinomas (p<0.05); while expression of Topo IIα in well differentiated carcinomas was lower than in poorly differentiated carcinomas (p<0.05). The expression of MDR factors was different between well and poorly differentiated carcinomas.
Different MDR characteristics were exhibited in well and poorly differentiated gastric carcinomas, which may be caused by different expressed MDR associated factors in these tissues.
背景/目的:评估体外化疗敏感性与分化型胃癌多药耐药(MDR)相关因子表达之间的关系。
收集不同分化程度的胃癌组织(65例),采用磺酰罗丹明B(SRB)法检测其对5-氟尿嘧啶、羟基喜树碱、紫杉醇、奥沙利铂、顺铂和表柔比星的化疗敏感性,采用免疫组织化学染色检测P-糖蛋白、谷胱甘肽S-转移酶π(GST-π)、拓扑异构酶IIα(Topo IIα)、p53、Bcl-2、Bax和生存素的表达。
5-氟尿嘧啶、奥沙利铂和顺铂对高分化肿瘤的抑制率低于低分化肿瘤(p<0.05)。高分化癌中P-糖蛋白、Bcl-2和生存素的表达高于低分化癌(p<0.05);而高分化癌中Topo IIα的表达低于低分化癌(p<0.05)。高分化癌和低分化癌之间MDR因子的表达不同。
高分化和低分化胃癌表现出不同的MDR特征,这可能是由这些组织中MDR相关因子的不同表达所致。